New York Cancer and Blood Specialists /ID# 259016 — Port Jefferson Station, New York

New York Cancer and Blood Specialists /ID# 259016 is a clinical research site located in Port Jefferson Station, New York, United States 11776-8060.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

New York Cancer and Blood Specialists /ID# 259016 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Large B-Cell Lymphoma, Classic Follicular Lymphoma.

Sponsors: Genmab.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Port Jefferson Station

Browse all research sites in New York · View every site in Port Jefferson Station

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Cancer and Blood Specialists /ID# 259016?

New York Cancer and Blood Specialists /ID# 259016 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Cancer and Blood Specialists /ID# 259016 conducted?

New York Cancer and Blood Specialists /ID# 259016 has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Classic Follicular Lymphoma.

Is New York Cancer and Blood Specialists /ID# 259016 accredited by Crixeo Clinical Trials?

New York Cancer and Blood Specialists /ID# 259016 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Cancer and Blood Specialists /ID# 259016?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.